Skip to main content
Livermore
Livermore
ZHEN

Captrust Financial Advisors

SEC CIK
0001512024
Latest filing
Aug 13, 2026

SUPN holding history

Supernus Pharmaceuticals, Inc. in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SUPN overviewAll 13F holders of SUPNFull Q2 2026 holdings

Shares (Q2 2026)
41,958
Value
$1.95M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of SUPN by Captrust Financial Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202641,958$1.95M<0.1%+1,706+4.2%AddedHolders
Q1 202640,252$2.08M<0.1%+21,649+116.4%AddedHolders
Q4 202518,603$924.6K<0.1%+188+1.0%AddedHolders
Q3 202518,415$880.1K<0.1%−1,997−9.8%ReducedHolders
Q2 202520,412$643.4K<0.1%+2,681+15.1%AddedHolders
Q1 202517,731$580.7K<0.1%+337+1.9%AddedHolders
Q4 202417,394$629.0K<0.1%+7,969+84.6%AddedHolders
Q3 20249,425$293.9K<0.1%−819−8.0%ReducedHolders
Q2 202410,244$274.0K<0.1%−87−0.8%ReducedHolders
Q1 202410,331$352.4K<0.1%+1,474+16.6%AddedHolders
Q4 20238,857$256.3K<0.1%−1,502−14.5%ReducedHolders
Q3 202310,359$285.6K<0.1%+10,359NewHolders
Q2 20230$00.0%−6,250−100.0%Sold outHolders
Q1 20236,250$226.4K<0.1%+209+3.5%AddedHolders
Q4 20226,041$215.5K<0.1%+127+2.1%AddedHolders
Q3 20225,914$200.0K<0.1%+2,710+84.6%AddedHolders
Q2 20223,204$93.0K<0.1%+221+7.4%AddedHolders
Q1 20222,983$96.0K<0.1%+1,850+163.3%AddedHolders
Q4 20211,133$33.0K<0.1%+91+8.7%AddedHolders
Q3 20211,042$28.0K<0.1%+146+16.3%AddedHolders
Q2 2021896$28.0K<0.1%−20−2.2%ReducedHolders
Q1 2021916$24.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.